• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Levosimendan Improves Heart Failure Progression

  • in AHA 2005 · Cardiovascular
  • — 16 Nov, 2005
Levosimendan Improves Heart Failure Progression
AudioMedica News
Levosimendan Improves Heart Failure Progression
Levosimendan Improves Heart Failure Progression
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-10"/>
Milton Packer
Milton Packer

In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer from the University of Texas.
[audio:https://www.audiomedica.com/podcasting/aha2005/Milton_Packer.mp3]

Click here for all the interviews from AHA 2005

You may also like...

  • Warfarin Trumps Platelet Agents in Atrial Fibrilation Warfarin Trumps Platelet Agents in Atrial Fibrilation 17 Nov, 2005
  • Telomere Length Predicts Coronary Heart Disease Risk and Statin Response Telomere Length Predicts Coronary Heart Disease Risk and Statin Response 19 Jan, 2007
  • Drug-eluting Stents: No Benefit in Vein Grafts Drug-eluting Stents: No Benefit in Vein Grafts 17 Nov, 2005
  • Looking for Atherosclerosis in the Legs Could Save Lives Looking for Atherosclerosis in the Legs Could Save Lives 5 Sep, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story COMMENTS
  • Next story Withholding Abciximab Infusion After Stenting
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • New Front Line Standard for Older Patients with…
    • Genomically Targeted Therapy Delays Advanced Breast…
    • Physical Therapy Boosts Brain Power in Hemiplegic…
  • Home
  • Cardiovascular
  • AHA 2005
  • Levosimendan Improves Heart Failure Progression

© COPYRIGHT 2020 AUDIOMEDICA.COM.